Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Dionisio Franco Barattini"'
Autor:
Dumitru Emanuel Dogaru, Serban Rosu, Dionisio Franco Barattini, Simone Guadagna, Luca Barattini, Bogdan Andor
Publikováno v:
JMIR Research Protocols, Vol 13, p e13642 (2024)
BackgroundOsteoarthritis (OA) is a disabling condition that affects more than one-third of people older than 65 years. Currently, 80% of these patients report movement limitations, 20% are unable to perform major activities of daily living, and appro
Externí odkaz:
https://doaj.org/article/4317cf1e66e74360991bd77308d0f9cb
Autor:
Noemi Venditti, Giulio Petronio Petronio, Antonio Guarnieri, Laura Pietrangelo, Angela Spicciato, Alessio Colalillo, Giovanna Paola Sabusco, Dionisio Franco Barattini, Aldo Di Franco, Stefano Papini, Francesco Cosentino, Roberto Di Marco
Publikováno v:
Diseases, Vol 12, Iss 10, p 237 (2024)
Background: Menopause, a natural phase in a woman’s life, often adversely affects physical, mental, sexual, and emotional well-being due to low estrogen levels. This study examines the impact of vaginal ovules with tocopherol acetate (Filme Gyno-V
Externí odkaz:
https://doaj.org/article/5ec140a09f8445d09dafcf8b161b42d5
Autor:
Fabio Cardinale, Dionisio Franco Barattini, Federica Sbrocca, Alessandro Centi, Greta Giuntini, Maria Morariu Bordea, Dorina Herteg, Serban Rosu, Cristian Radu Matei
Publikováno v:
JMIR Research Protocols, Vol 13, p e53703 (2024)
BackgroundA dietary supplement containing Pelargonium sidoides extract, propolis, zinc, and honey has been recently developed and proven to be an effective adjuvant in clinical practice for seasonal diseases and the treatment of respiratory tract dis
Externí odkaz:
https://doaj.org/article/1a67b32447b54cc2ac51b03918baa9f6
Autor:
Filippo Murina, Paolo Inghirami, Marius Biriș, Daniela Sîrbu, Dionisio Franco Barattini, Luca Ivan Ardolino, Mario Mangrella, Elena Casolati, Serban Marius Roșu, Ciprian Crișan
Publikováno v:
Journal of International Medical Research, Vol 52 (2024)
Objective Recurrent bacterial vaginosis (RBV) after antibiotic treatment has relapse rates of 35% within 3 months and 60% within 12 months. A medical device containing polycarbophil, lauryl glucoside, and glycerides (PLGG) inhibits bacterial growth a
Externí odkaz:
https://doaj.org/article/b186e5383ef74704993a854a4002d8c9
Autor:
Fabio Cardinale, Dionisio Franco Barattini, Valentina Martinucci, Maria Morariu Bordea, Luca Barattini, Serban Rosu
Publikováno v:
Pharmaceuticals, Vol 17, Iss 6, p 804 (2024)
Physicians are currently finding products for pediatric respiratory diseases of viral etiology to reduce the inappropriate use of antibiotic therapy. This study evaluated PediaFlù (Pediatrica S.r.l.), a dietary supplement already on the market compo
Externí odkaz:
https://doaj.org/article/b94412ab38fb407cbb210209c51f385d
Autor:
Filippo Murina, Paolo Inghirami, Marius Biriș, Daniela Sîrbu, Dionisio Franco Barattini, Federica Sbrocca, Luca Ivan Ardolino, Mario Mangrella, Elena Casolati, Serban Roșu, Ciprian Doru Crișan
Publikováno v:
JMIR Research Protocols, Vol 12, p e42787 (2023)
BackgroundThe medical literature has reported that recurrent bacterial vaginosis (RBV) has a relapse rate of 35% within 3 months and 60% within 12 months after antibiotic administration. Products that are able to provide a barrier effect against the
Externí odkaz:
https://doaj.org/article/58b82925c4804428a56a1d056caa78bb
Autor:
Angelo Cagnacci, Dionisio Franco Barattini, Elena Casolati, Alberto Pecoroni, Mario Mangrella, Liviu Cristian Patrascu
Publikováno v:
European Journal of Obstetrics & Gynecology and Reproductive Biology. 270:239-245
During menopausal transition, women are frequently affected by vulvovaginal atrophy (VVA), due to the decline of estrogen levels. Resulting symptoms are itching, burning, dyspareunia, and vaginal dryness (reported in up to 85%). The aim of this trial
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::266abc2473c165727add3d1a6bd421f7
https://doi.org/10.1016/j.ejogrb.2022.01.021
https://doi.org/10.1016/j.ejogrb.2022.01.021
Autor:
Filippo Murina, Paolo Inghirami, Marius Biriș, Daniela Sîrbu, Dionisio Franco Barattini, Federica Sbrocca, Luca Ivan Ardolino, Mario Mangrella, Elena Casolati, Serban Marius Roșu, Ciprian Crișan
BACKGROUND Medical literature has evidenced in recurrent bacterial vaginosis a relapse rate of 35% within 3 months and 60% within 12 months after antibiotic administration. The products able to create a barrier effect against the biofilm produced by
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::60b09950ceac5d3eef327b72222cb708
https://doi.org/10.2196/preprints.42787
https://doi.org/10.2196/preprints.42787
Autor:
Filippo Murina, Paolo Inghirami, Marius Biriș, Daniela Sîrbu, Dionisio Franco Barattini, Federica Sbrocca, Luca Ivan Ardolino, Mario Mangrella, Elena Casolati, Serban Marius Roșu, Ciprian Crișan
Publikováno v:
JMIR Research Protocols.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::34f0a5cfc6c62768fd4f0b1dc89a4102
https://doi.org/10.2196/42787
https://doi.org/10.2196/42787
Autor:
Filippo Murina, Paolo Inghirami, Marius Biriș, Daniela Sîrbu, Dionisio Franco Barattini, Luca Ivan Ardolino, Mario Mangrella, Elena Casolati, Serban Marius Roșu, Ciprian Crișan
Recurrent bacterial vaginosis (RBV) after antibiotic treatments has a relapse rate of 35% within 3 months and 60% within 12 months. Products containing polycarbophil (PLGG), that inhibits bacterial growth and mucoadhesive property, can impair biofilm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2bc3f272e1e021c26bbf655a0a16cc49
https://doi.org/10.20944/preprints202209.0131.v1
https://doi.org/10.20944/preprints202209.0131.v1